Design, Synthesis, Characterization and Anticancer properties of Novel derivatives of 2-(4-t-butyl)-5-(5-Aryl substituted-1, 3, 4-oxadiazol-2-yl) pyridine

preprint OA: closed CC-BY-4.0
📄 Open PDF View at publisher

Abstract

Abstract In our present study author has synthesized novel derivatives of 1, 3, 4-oxadiazoles by linear synthetic method and characterized the compounds by LCMS, 1H-NMR and 13C spectral analysis. In this research work 2-(4-t-butyl-phenyl)-5-(5-aryl substituted-[1, 3, 4] oxadiazol-2-yl)-pyridine have been synthesized by the oxidative cyclization reaction and purified by column-chromatography. The 6-(4-t-butyl-phenyl)-nicotinic acid hydrazide which upon reacted with aldehydes (a-f) and got the Schiff base derivatives. The compounds 7a-7f were screened for MTT assay against HeLa, MCF7and Caco-2 Cell lines. A graph was plotted against percentage viability and concentration of the compounds and obtained the IC50 values. Among the synthesized novel derivatives of 1, 3, 4-oxdiazoles two compounds 7b and 7d exhibited good cytotoxicity on MCF7 cell lines having an IC50 of 6.74µM and 3.69 µM respectively. On Caco-2 cell lines the compounds 7c, 7d and 7f have showed moderate cytotoxicity having IC50 of 24.6µM, 55.5µM and 24.8µM respectively.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC-BY-4.0